General
CALL TO ACTION ON SELLING SICKNESS GOES INTERACTIVE
Our Call to Action went live on April 22, 2013, and as of this moment, 2 weeks later, we have 278 individual endorsers from all over the world, with more signing every day. Our editorial […]
WHO CAN WE TRUST?
A new study just published in the Journal of General Internal Medicine involving Canadian, US and French physicians shows that the majority of family doctors receive little or no information about a drug’s harmful side […]
“YOUR VOICE, YOUR WISH” – A NEW MARKETING SCAM ABOUT WOMEN’S SEXUALITY
Following the FDA’s 2010 rejection of flibanserin, the ineffective and possibly dangerous CNS drug proposed for “female sexual dysfunction (FSD)” and the 2nd FSD drug to fail at the FDA, the International Society for the […]
DSM-5 PETITIONS
Next month is the long-awaited debut of the fifth edition of the Diagnostic and Statistical Manual of the American Psychiatric Association, the DSM-V (now known as DSM-5, a change which is odd since even football […]
CONFERENCES, CONFERENCES AND MORE CONFERENCES
Earlier this week I (KW) was invited to Washington to attend “Using Comparative Effectiveness Research to Improve Health Care” sponsored by Consumer Reports and National Research Center for Women and Families. It brought together over […]
FIRST ROAD TEST
I (LT) just gave a workshop about “Selling Sickness, 2013” at the annual meeting of the Association for Women in Psychology (AWP), held this weekend in sunny Salt Lake City, Utah. A lively group turned […]
WE DID IT! YOU DID IT! NEXT STEPS?
It seems self-serving to say that the Selling Sickness conference was a blockbuster, but it was. Attended by around 225 advocates, academics, journalists, health care providers, legislators, students, lawyers, librarians, writers From Russia, Finland, Germany, […]
